Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study Links Private-Label OTC Purchases To Pharma Knowledge

This article was originally published in The Tan Sheet

Executive Summary

Physicians and pharmacists are significantly more likely than average consumers to purchase private-label OTC headache remedies, a marketing study finds. The researchers say brands in categories with largely homogenous products may derive premiums through “misinformation” in advertising.

Advertisement

Related Content

Perrigo Campaigns For Rational OTC Shopping Over Brand Loyalty
Bayer Advances Aspirin Pain Relief With Pro-Release Technology

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel